-- Earnings Flash (KZR) KEZAR LIFE SCIENCES Reports Q2 Loss $-0.25
4:04PM ET 8/11/2022 MT Newswires...
...
Kezar Life Sciences (KZR) said late Monday that it has appointed Nick Mordwinkin as chief business officer of the company. Mordwinkin joins the...
Health care stocks still were mostly lower this afternoon, with the NYSE Health Care Index and the SPDR Health Care Select Sector ETF (XLV) both falling...
Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 1.6% and the SPDR Health Care Select Sector ETF (XLV) slipping...
Kezar Life Sciences (KZR) said a phase 2 clinical trial evaluating zetomipzomib for active lupus nephritis, a kidney inflammation, showed that 11 of 17...
Health care stocks were mixed pre-bell Tuesday. The Health Care SPDR (XLV) was up 0.42%, and the iShares NASDAQ Biotechnology Index (IBB) was recently...
US stocks look set to open higher Tuesday ahead of consumer confidence index data and house price index measurements. The consumer confidence index for...
Health care stocks were mixed pre-bell Tuesday. The Health Care SPDR (XLV) was up 0.42% and the iShares NASDAQ Biotechnology Index (IBB) was recently...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
US stock futures were higher during Tuesday's premarket session ahead of consumer confidence data and house price index measurements. The consumer...